The Envirocleanse mission is to provide the world with a sustainable biocide. The patent-pending technology behind Envirocleanse was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase its size and scope. The flagship of Envirocleanse is the EPA-registered disinfectant known as Envirocleanse-A (the “A” stands for Anolite). The Envirocleanse-A solution is hypochlorous acid (HOCl), a nontoxic, non-corrosive biodegradable disinfectant. To find out more, please contact one of our listed team members.